Published in J Urol on May 01, 1998
Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol (2010) 0.92
Peyronie's Disease: A Review. Rev Urol (2003) 0.89
Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie's disease. World J Urol (2008) 0.87
PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT. Curr Sex Health Rep (2015) 0.81
The pathophysiology of Peyronie's disease. Arab J Urol (2013) 0.79
Surgical trauma on the tunica albuginea. J Urol (1998) 0.75
Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med (1998) 12.67
Detection and identification of Mycobacterium tuberculosis by DNA amplification. J Clin Microbiol (1990) 5.48
Clinical and pathological features of bacillary peliosis hepatis in association with human immunodeficiency virus infection. N Engl J Med (1990) 3.70
Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S. Infect Immun (1997) 3.49
Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res (1993) 3.02
Trans-activation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein. Proc Natl Acad Sci U S A (1988) 2.79
Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (1990) 2.69
Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol (1996) 2.68
Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev Biol Anim (1995) 2.63
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene (2009) 2.61
Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol (1995) 2.46
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene (2007) 2.28
Granuloma annulare and human immunodeficiency virus infection. Arch Dermatol (1999) 2.26
Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Pathol (1990) 2.13
Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J (2001) 2.03
Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J (1998) 1.97
Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts. Mol Cell Biol (1995) 1.95
Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology (1985) 1.93
Epithelioid haemangioma-like vascular proliferation in AIDS: manifestation of cat scratch disease bacillus infection? Lancet (1988) 1.92
Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation (1998) 1.86
Transport of hepatitis B virus precore protein into the nucleus after cleavage of its signal peptide. J Virol (1989) 1.85
Penile length in the flaccid and erect states: guidelines for penile augmentation. J Urol (1996) 1.85
Hemodynamics of papaverine- and phentolamine-induced penile erection. J Urol (1986) 1.74
A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res (2000) 1.70
Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res (2003) 1.68
Hepatitis B virus RNA element that facilitates accumulation of surface gene transcripts in the cytoplasm. J Virol (1994) 1.66
Structural alterations in the tunica albuginea of the penis: impact of Peyronie's disease, ageing and impotence. Br J Urol (1997) 1.64
Complications of penile lengthening and augmentation seen at 1 referral center. J Urol (1996) 1.64
Neuroanatomy of penile erection: its relevance to iatrogenic impotence. J Urol (1984) 1.60
Effect of simulated birth trauma on the urinary continence mechanism in the rat. Urology (1998) 1.59
Polyomavirus-induced interstitial nephritis in two renal transplant recipients: case reports and review of the literature. Am J Kidney Dis (1997) 1.59
Lupus-like kidney disease in mice deficient in the Src family tyrosine kinases Lyn and Fyn. Curr Biol (2001) 1.58
Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum. J Virol (1997) 1.56
The effect of simulated birth trauma and/or ovariectomy on rodent continence mechanism. Part I: functional and structural change. J Urol (2001) 1.53
Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein. J Virol (1999) 1.52
Hepatocyte-specific expression of the hepatitis B virus core promoter depends on both positive and negative regulation. Mol Cell Biol (1993) 1.50
The functional significance of microRNA-145 in prostate cancer. Br J Cancer (2010) 1.48
Bacteriophage f1 gene II and X proteins. Isolation and characterization of the products of two overlapping genes. J Biol Chem (1981) 1.43
Paracrine regulation of apoptosis by steroid hormones in the male and female reproductive system. Cell Death Differ (2001) 1.43
Priapism: a refined approach to diagnosis and treatment. J Urol (1986) 1.42
A human prostatic epithelial model of hormonal carcinogenesis. Cancer Res (2001) 1.40
Can intracatheter retention of antifungal agents cure fungal peritonitis? Two cases successfully treated without catheter removal. Perit Dial Int (1991) 1.38
Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med (1997) 1.37
Activation of class I major histocompatibility complex gene expression by hepatitis B virus. J Virol (1990) 1.37
Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res (2000) 1.35
Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human. Br J Urol (1998) 1.33
Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression. Cancer Res (2000) 1.32
Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest (1991) 1.32
Translational control of bacteriophage f1 gene II and gene X proteins by gene V protein. Cell (1982) 1.31
Histone deacetylase and DNA methyltransferase in human prostate cancer. Biochem Biophys Res Commun (2001) 1.30
Physiology of erection and pharmacological management of impotence. J Urol (1987) 1.30
The effect of vascular endothelial growth factor and brain-derived neurotrophic factor on cavernosal nerve regeneration in a nerve-crush rat model. BJU Int (2003) 1.29
Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression. J Urol (1997) 1.28
The ubiquitous transcription factor Oct-1 and the liver-specific factor HNF-1 are both required to activate transcription of a hepatitis B virus promoter. Mol Cell Biol (1991) 1.26
Intracellular retention of surface protein by a hepatitis B virus mutant that releases virion particles. J Virol (1996) 1.25
Rapid detection of cutaneous herpes simplex virus infection with the polymerase chain reaction. J Invest Dermatol (1989) 1.25
A model system for studying membrane biogenesis. Overexpression of cytochrome b5 in yeast results in marked proliferation of the intracellular membrane. J Cell Sci (1993) 1.22
Acute renal failure due to raw bile of grass carp (Clenopharyngodon idellus). J Med Assoc Thai (1978) 1.20
Bacillary angiomatosis. The histopathology and differential diagnosis of a pseudoneoplastic infection in patients with human immunodeficiency virus disease. Am J Surg Pathol (1989) 1.19
Formation of intracellular particles by hepatitis B virus large surface protein. J Virol (1997) 1.19
Differential regulation of the hepatitis B virus surface gene promoters by a second viral enhancer. J Biol Chem (1990) 1.18
Bladder acellular matrix graft: in vivo functional properties of the regenerated rat bladder. Urol Res (1999) 1.17
An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol (1997) 1.17
Primitive polypoid granular-cell tumor and other cutaneous granular-cell neoplasms of apparent nonneural origin. Am J Surg Pathol (1991) 1.16
Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer (1997) 1.16
Mechanisms of venous occlusion during canine penile erection: an anatomic demonstration. J Urol (1987) 1.14
microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer. Br J Cancer (2013) 1.14
Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle. Acta Anat (Basel) (1996) 1.14
Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells. Br J Cancer (2009) 1.14
Effects of a frequent double-nucleotide basal core promoter mutation and its putative single-nucleotide precursor mutations on hepatitis B virus gene expression and replication. J Gen Virol (1997) 1.14
Tumour suppressor microRNA-584 directly targets oncogene Rock-1 and decreases invasion ability in human clear cell renal cell carcinoma. Br J Cancer (2010) 1.13
Health issues of men: prevalence and correlates of erectile dysfunction. J Urol (2005) 1.13
Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol (2001) 1.12
The hepatitis B virus S promoter comprises A CCAAT motif and two initiation regions. J Biol Chem (1991) 1.12
Neurotrophic effects of vascular endothelial growth factor and neurotrophins on cultured major pelvic ganglia. BJU Int (2003) 1.12
Cloning and characterization of human estrogen receptor beta promoter. Biochem Biophys Res Commun (2000) 1.11
Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Cancer Res (2001) 1.11
Identification of glyceraldehyde-3-phosphate dehydrogenase as a cellular protein that binds to the hepatitis B virus posttranscriptional regulatory element. Virology (1998) 1.10
Normal development and carcinogenesis of the prostate. A unifying hypothesis. Ann N Y Acad Sci (1996) 1.10
The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J Urol (2001) 1.10
Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anat (Basel) (1996) 1.09
Cell surface sialoprotein alterations in metastatic murine colon cancer cell lines selected in an animal model for colon cancer metastasis. Cancer Res (1990) 1.09
Lack of mycobacterial DNA in Crohn's disease tissue. Lancet (1991) 1.08
Penile replantation: current concepts. J Urol (1985) 1.07
Erectile dysfunction: problems and challenges. J Urol (1993) 1.07
Citrate alterations in primary and metastatic human prostatic adenocarcinomas: 1H magnetic resonance spectroscopy and biochemical study. Magn Reson Med (1993) 1.06
CpG hypermethylation of the promoter region inactivates the estrogen receptor-beta gene in patients with prostate carcinoma. Cancer (2001) 1.05
Peyronie's disease: a critical appraisal of current diagnosis and treatment. Int J Impot Res (2008) 1.05
Clinical significance of sacral and pudendal nerve anatomy. J Urol (1988) 1.05
trans-activation by the hepatitis B virus X protein shows cell-type specificity. Virology (1989) 1.05
Deletion of Y-chromosome specific genes in human prostate cancer. J Urol (2000) 1.04
Cloning and characterization of a human ribosomal protein gene with enhanced expression in fetal and neoplastic cells. Nucleic Acids Res (1987) 1.04
Decreased trabecular smooth muscle and caveolin-1 expression in the penile tissue of aged rats. J Urol (2001) 1.04